LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

Inicio・Lista de Acciones・West Pharmaceutical Services Inc

West Pharmaceutical Services Inc

Cerrado

SectorSanidad

269.3 1.04

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

264

Máximo

275.31

Métricas clave
By Trading Economics
Ingresos	8.2M 140M
Ventas	38M 804M
P/B Media del Sector	40.335 76.798
BPA	1.96
Rentabilidad por dividendo	0.31
Margen de beneficios	17.406
Empleados	10,600
EBITDA	19M 217M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+28.26% upside

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	0.31% 2.37%
Fecha Próximo Dividendo	4 feb 2026
Próxima Fecha de Ex Dividendo	28 ene 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-209M 20B
Apertura anterior	268.26
Cierre anterior	269.3

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

213.26 / 219.27 Soporte y Resistencia

West Pharmaceutical Services Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

17 dic 2025, 23:50 UTC

Acciones populares

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

17 dic 2025, 23:20 UTC

Ganancias

Correction to Micron Logs Sales Jump Article

17 dic 2025, 23:07 UTC

Ganancias

Micron Logs Sales Jump, Sees Further Growth as AI Demand Outpaces Supply -- Update

17 dic 2025, 21:37 UTC

Ganancias

Micron Technology 1Q Sales Jump 57%, Led By Memory Growth

17 dic 2025, 23:53 UTC

Charlas de Mercado

Gold Edges Higher, Supported by Some Tailwinds -- Market Talk

17 dic 2025, 23:43 UTC

Charlas de Mercado

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

17 dic 2025, 23:06 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Transaction Expected to Be Closed in 2H of Calendar Year 2026

17 dic 2025, 23:05 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Currently No Plans of Issuing New Shares in Asahi

17 dic 2025, 23:04 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Funds to Be Provided Via Borrowings From Financial Institutions or Cash on Hand

17 dic 2025, 23:03 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Acquisition of 53.68% Stake in UDV (Kenya) is $646M on Equity Value Basis

17 dic 2025, 23:02 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Acquisition of 100% Stake in Diageo Kenya is $2.354B on Equity Value Basis

17 dic 2025, 22:59 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Deal Part of Strategy Under Medium- to Long-Term Management Policy

17 dic 2025, 22:57 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: To Indirectly Acquire 65.00% Stake in East African Breweries PLC

17 dic 2025, 22:56 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Stakes Acquired From Two Subsidiaries of Diageo Plc

17 dic 2025, 22:55 UTC

Adquisiciones, fusiones, absorciones

Asahi Group Holdings: To Acquire 100% Stake in Diageo Kenya Ltd., 53.68% Stake in UVD (Kenya) Ltd.

17 dic 2025, 22:49 UTC

Charlas de Mercado

Sandfire Resources Production Pipeline Strength Questioned -- Market Talk

17 dic 2025, 21:58 UTC

Ganancias

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 dic 2025, 21:50 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

17 dic 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

17 dic 2025, 21:46 UTC

Ganancias

Salesforce and Other AI Stocks That Can Catch Up to the Pack -- Barrons.com

17 dic 2025, 21:20 UTC

Ganancias

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 dic 2025, 21:10 UTC

Ganancias

Micron Beats Earnings. The Stock Is Rising. -- Barrons.com

17 dic 2025, 21:05 UTC

Ganancias

Micron Technology Anticipates Business Performance to Continue Strengthening Through FY26

17 dic 2025, 21:04 UTC

Ganancias

Micron Technology: 2Q Outlook Reflects Substantial Records Across Rev, Gross Margin, EPS and Free Cash Flow >MU

17 dic 2025, 21:04 UTC

Ganancias

Micron Technology Sees 2Q Oper Expenses $1.56B, Plus or Minus $20M >MU

17 dic 2025, 21:03 UTC

Ganancias

Micron Technology Sees 2Q Adj EPS $8.42, Plus or Minus 20c >MU

17 dic 2025, 21:03 UTC

Ganancias

Micron Technology Sees 2Q EPS $8.19, Plus or Minus 20c >MU

17 dic 2025, 21:03 UTC

Ganancias

Micron Technology Sees 2Q Revenue $18.7B, Plus or Minus $400M >MU

17 dic 2025, 21:02 UTC

Ganancias

Micron Technology 1Q Operating Cash Flow $8.41 B >MU

17 dic 2025, 21:01 UTC

Ganancias

Micron Technology 1Q Rev $13.64B >MU

Comparación entre iguales

Cambio de precio

West Pharmaceutical Services Inc previsión

Precio Objetivo

By TipRanks

28.26% repunte

Estimación a 12 Meses

Media 348.7 USD 28.26%

Máximo 375 USD

Mínimo 285 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para West Pharmaceutical Services Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

12 ratings

Comprar

Mantener

Vender

De acuerdo con 12 analistas que ofrecen calificaciones bursátiles a para West Pharmaceutical Services Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

213.26 / 219.27Soporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bearish.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.